Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP630732.RAeu4UdpeIlkmB4bVnx7q-GGNHN3x3DHKp3n-Gzu0cZ2Y130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP630732.RAeu4UdpeIlkmB4bVnx7q-GGNHN3x3DHKp3n-Gzu0cZ2Y130_assertion type Assertion NP630732.RAeu4UdpeIlkmB4bVnx7q-GGNHN3x3DHKp3n-Gzu0cZ2Y130_head.
- NP630732.RAeu4UdpeIlkmB4bVnx7q-GGNHN3x3DHKp3n-Gzu0cZ2Y130_assertion wasGeneratedBy ECO_0000203 NP630732.RAeu4UdpeIlkmB4bVnx7q-GGNHN3x3DHKp3n-Gzu0cZ2Y130_provenance.
- NP630732.RAeu4UdpeIlkmB4bVnx7q-GGNHN3x3DHKp3n-Gzu0cZ2Y130_assertion wasDerivedFrom befree-2016 NP630732.RAeu4UdpeIlkmB4bVnx7q-GGNHN3x3DHKp3n-Gzu0cZ2Y130_provenance.
- NP630732.RAeu4UdpeIlkmB4bVnx7q-GGNHN3x3DHKp3n-Gzu0cZ2Y130_assertion SIO_000772 17878251 NP630732.RAeu4UdpeIlkmB4bVnx7q-GGNHN3x3DHKp3n-Gzu0cZ2Y130_provenance.
- NP630732.RAeu4UdpeIlkmB4bVnx7q-GGNHN3x3DHKp3n-Gzu0cZ2Y130_assertion evidence source_evidence_literature NP630732.RAeu4UdpeIlkmB4bVnx7q-GGNHN3x3DHKp3n-Gzu0cZ2Y130_provenance.
- NP630732.RAeu4UdpeIlkmB4bVnx7q-GGNHN3x3DHKp3n-Gzu0cZ2Y130_assertion description "[The objective of the investigation was to study the efficacy of a MEK1/2 inhibitor in thyroid cancer preclinical models with defined BRAF mutation status.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP630732.RAeu4UdpeIlkmB4bVnx7q-GGNHN3x3DHKp3n-Gzu0cZ2Y130_provenance.